MedTrace Logo

Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant

NCT01555515 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2016-09-13

No results posted yet for this study

Summary

In this End Stage Renal Disease (ESRD) patients who need Erythropoietin (epo) hormone will get it by a small implant of skin using their own skin, the implant will be treated in the laboratory and programmed to secrete Epo. The implant secretes the patients own epo minimizing the need for injections for a period of up to 6 months.

Conditions

Interventions

PROCEDURE

implantation of autologous skin graft after ex-vivo treatment

Subcutan implantation of autologous skin graft after ex-vivo treatment

BIOLOGICAL

Subcutan implantation of autologus skin graft after ex-vivo treatment

Subcutan implantation of autologus skin graft after ex-vivo treatment

Sponsors & Collaborators

  • Medgenics Medical Israel Ltd.

    lead INDUSTRY

Principal Investigators

  • Doron Schwartz, Professor · Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-06-30
Completion
2014-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01555515 on ClinicalTrials.gov